nodes	percent_of_prediction	percent_of_DWPC	metapath
Bepridil—CYP2D6—breast cancer	0.0946	0.583	CbGaD
Bepridil—ABCB1—breast cancer	0.0676	0.417	CbGaD
Bepridil—Dextropropoxyphene—Toremifene—breast cancer	0.0568	0.142	CrCrCtD
Bepridil—Phenoxybenzamine—Toremifene—breast cancer	0.0568	0.142	CrCrCtD
Bepridil—Benzphetamine—Toremifene—breast cancer	0.0398	0.0991	CrCrCtD
Bepridil—Benzyl Benzoate—Toremifene—breast cancer	0.0368	0.0918	CrCrCtD
Bepridil—Phenoxybenzamine—Tamoxifen—breast cancer	0.0357	0.0889	CrCrCtD
Bepridil—Dextropropoxyphene—Tamoxifen—breast cancer	0.0357	0.0889	CrCrCtD
Bepridil—Diphenhydramine—Toremifene—breast cancer	0.0353	0.088	CrCrCtD
Bepridil—Tripelennamine—Tamoxifen—breast cancer	0.034	0.0847	CrCrCtD
Bepridil—Benzphetamine—Tamoxifen—breast cancer	0.025	0.0622	CrCrCtD
Bepridil—Benzyl Benzoate—Tamoxifen—breast cancer	0.0231	0.0577	CrCrCtD
Bepridil—Diphenhydramine—Tamoxifen—breast cancer	0.0222	0.0553	CrCrCtD
Bepridil—ABCB1—Toremifene—breast cancer	0.0195	0.157	CbGbCtD
Bepridil—CYP2D6—Idarubicin—breast cancer	0.0153	0.122	CbGbCtD
Bepridil—ABCB1—Lapatinib—breast cancer	0.0143	0.114	CbGbCtD
Bepridil—ABCB1—Vinorelbine—breast cancer	0.00791	0.0634	CbGbCtD
Bepridil—CYP2D6—Vinorelbine—breast cancer	0.00745	0.0598	CbGbCtD
Bepridil—ABCB1—Tamoxifen—breast cancer	0.00714	0.0573	CbGbCtD
Bepridil—ABCB1—Mitoxantrone—breast cancer	0.00696	0.0559	CbGbCtD
Bepridil—CYP2D6—Tamoxifen—breast cancer	0.00673	0.054	CbGbCtD
Bepridil—ABCB1—Gemcitabine—breast cancer	0.00615	0.0493	CbGbCtD
Bepridil—ABCB1—Paclitaxel—breast cancer	0.00556	0.0446	CbGbCtD
Bepridil—ABCB1—Irinotecan—breast cancer	0.00548	0.044	CbGbCtD
Bepridil—ABCB1—Vinblastine—breast cancer	0.00487	0.0391	CbGbCtD
Bepridil—CYP2D6—Vinblastine—breast cancer	0.00459	0.0368	CbGbCtD
Bepridil—ABCB1—Docetaxel—breast cancer	0.00402	0.0322	CbGbCtD
Bepridil—ABCB1—Doxorubicin—breast cancer	0.00299	0.024	CbGbCtD
Bepridil—ABCB1—Methotrexate—breast cancer	0.0029	0.0233	CbGbCtD
Bepridil—CYP2D6—Doxorubicin—breast cancer	0.00282	0.0226	CbGbCtD
Bepridil—CACNA2D2—mammary gland—breast cancer	0.00169	0.0305	CbGeAlD
Bepridil—TNNC1—endometrium—breast cancer	0.001	0.0181	CbGeAlD
Bepridil—CACNA1A—adrenal gland—breast cancer	0.000971	0.0175	CbGeAlD
Bepridil—PDE1B—adipose tissue—breast cancer	0.000944	0.017	CbGeAlD
Bepridil—TNNC1—pituitary gland—breast cancer	0.000909	0.0164	CbGeAlD
Bepridil—TNNC1—adipose tissue—breast cancer	0.000905	0.0163	CbGeAlD
Bepridil—CALM3—mammary gland—breast cancer	0.000876	0.0158	CbGeAlD
Bepridil—PDE1B—female reproductive system—breast cancer	0.000868	0.0156	CbGeAlD
Bepridil—PDE1B—adrenal gland—breast cancer	0.000847	0.0153	CbGeAlD
Bepridil—TNNC1—adrenal gland—breast cancer	0.000812	0.0146	CbGeAlD
Bepridil—PDE1A—uterus—breast cancer	0.000809	0.0146	CbGeAlD
Bepridil—PDE1A—adipose tissue—breast cancer	0.000791	0.0143	CbGeAlD
Bepridil—ATP1A1—mammary gland—breast cancer	0.000781	0.0141	CbGeAlD
Bepridil—CACNA2D2—pituitary gland—breast cancer	0.000765	0.0138	CbGeAlD
Bepridil—KCNQ1—pituitary gland—breast cancer	0.000739	0.0133	CbGeAlD
Bepridil—KCNQ1—adipose tissue—breast cancer	0.000736	0.0133	CbGeAlD
Bepridil—PDE1B—endocrine gland—breast cancer	0.000734	0.0132	CbGeAlD
Bepridil—PDE1A—female reproductive system—breast cancer	0.000727	0.0131	CbGeAlD
Bepridil—CALM3—nipple—breast cancer	0.000725	0.0131	CbGeAlD
Bepridil—PDE1A—adrenal gland—breast cancer	0.00071	0.0128	CbGeAlD
Bepridil—CALM1—mammary gland—breast cancer	0.000685	0.0123	CbGeAlD
Bepridil—CACNA2D2—adrenal gland—breast cancer	0.000683	0.0123	CbGeAlD
Bepridil—KCNQ1—female reproductive system—breast cancer	0.000676	0.0122	CbGeAlD
Bepridil—PDE1A—female gonad—breast cancer	0.000662	0.0119	CbGeAlD
Bepridil—KCNQ1—adrenal gland—breast cancer	0.00066	0.0119	CbGeAlD
Bepridil—ATP1A1—nipple—breast cancer	0.000646	0.0116	CbGeAlD
Bepridil—KCNQ1—bone marrow—breast cancer	0.000638	0.0115	CbGeAlD
Bepridil—CACNA1H—uterus—breast cancer	0.000632	0.0114	CbGeAlD
Bepridil—CACNA1H—pituitary gland—breast cancer	0.00062	0.0112	CbGeAlD
Bepridil—PDE1A—endocrine gland—breast cancer	0.000616	0.0111	CbGeAlD
Bepridil—KCNQ1—female gonad—breast cancer	0.000615	0.0111	CbGeAlD
Bepridil—CACNA2D2—endocrine gland—breast cancer	0.000592	0.0107	CbGeAlD
Bepridil—KCNQ1—endocrine gland—breast cancer	0.000572	0.0103	CbGeAlD
Bepridil—CALM2—nipple—breast cancer	0.000569	0.0102	CbGeAlD
Bepridil—CACNA1H—female reproductive system—breast cancer	0.000568	0.0102	CbGeAlD
Bepridil—CALM1—nipple—breast cancer	0.000566	0.0102	CbGeAlD
Bepridil—CACNA1H—adrenal gland—breast cancer	0.000554	0.00998	CbGeAlD
Bepridil—ATP1A1—embryo—breast cancer	0.000533	0.0096	CbGeAlD
Bepridil—CACNA1H—female gonad—breast cancer	0.000517	0.00931	CbGeAlD
Bepridil—KCNH2—nipple—breast cancer	0.000515	0.00928	CbGeAlD
Bepridil—CACNA1D—pituitary gland—breast cancer	0.000512	0.00922	CbGeAlD
Bepridil—PDE1B—lymph node—breast cancer	0.000508	0.00915	CbGeAlD
Bepridil—TNNC1—lymph node—breast cancer	0.000487	0.00877	CbGeAlD
Bepridil—CACNA1H—endocrine gland—breast cancer	0.000481	0.00866	CbGeAlD
Bepridil—CACNA1C—pituitary gland—breast cancer	0.000473	0.00851	CbGeAlD
Bepridil—CACNA1C—adipose tissue—breast cancer	0.000471	0.00848	CbGeAlD
Bepridil—CALM2—embryo—breast cancer	0.000469	0.00846	CbGeAlD
Bepridil—CALM1—embryo—breast cancer	0.000467	0.00842	CbGeAlD
Bepridil—CACNA1D—adrenal gland—breast cancer	0.000457	0.00824	CbGeAlD
Bepridil—CALM3—endometrium—breast cancer	0.000437	0.00788	CbGeAlD
Bepridil—ATP1A1—epithelium—breast cancer	0.000435	0.00784	CbGeAlD
Bepridil—CACNA1C—female reproductive system—breast cancer	0.000433	0.00779	CbGeAlD
Bepridil—PDE1A—lymph node—breast cancer	0.000425	0.00766	CbGeAlD
Bepridil—CACNA1C—adrenal gland—breast cancer	0.000422	0.00761	CbGeAlD
Bepridil—ATP1A1—skin of body—breast cancer	0.000414	0.00745	CbGeAlD
Bepridil—CACNA2D2—lymph node—breast cancer	0.00041	0.00738	CbGeAlD
Bepridil—CALM3—uterus—breast cancer	0.000403	0.00726	CbGeAlD
Bepridil—CACNA1D—endocrine gland—breast cancer	0.000397	0.00714	CbGeAlD
Bepridil—CALM3—pituitary gland—breast cancer	0.000396	0.00713	CbGeAlD
Bepridil—KCNQ1—lymph node—breast cancer	0.000396	0.00713	CbGeAlD
Bepridil—CALM3—adipose tissue—breast cancer	0.000394	0.0071	CbGeAlD
Bepridil—ATP1A1—endometrium—breast cancer	0.00039	0.00703	CbGeAlD
Bepridil—CALM2—epithelium—breast cancer	0.000383	0.0069	CbGeAlD
Bepridil—CALM1—epithelium—breast cancer	0.000381	0.00687	CbGeAlD
Bepridil—CACNA1C—endocrine gland—breast cancer	0.000366	0.0066	CbGeAlD
Bepridil—CALM2—skin of body—breast cancer	0.000364	0.00656	CbGeAlD
Bepridil—CALM1—skin of body—breast cancer	0.000363	0.00653	CbGeAlD
Bepridil—ATP1A1—uterus—breast cancer	0.000359	0.00648	CbGeAlD
Bepridil—CALM3—adrenal gland—breast cancer	0.000354	0.00637	CbGeAlD
Bepridil—ATP1A1—pituitary gland—breast cancer	0.000353	0.00636	CbGeAlD
Bepridil—ATP1A1—adipose tissue—breast cancer	0.000352	0.00633	CbGeAlD
Bepridil—CALM2—endometrium—breast cancer	0.000344	0.00619	CbGeAlD
Bepridil—CALM3—bone marrow—breast cancer	0.000342	0.00616	CbGeAlD
Bepridil—CALM1—endometrium—breast cancer	0.000342	0.00616	CbGeAlD
Bepridil—CACNA1H—lymph node—breast cancer	0.000332	0.00598	CbGeAlD
Bepridil—CALM3—female gonad—breast cancer	0.00033	0.00594	CbGeAlD
Bepridil—ATP1A1—female reproductive system—breast cancer	0.000323	0.00582	CbGeAlD
Bepridil—CALM2—uterus—breast cancer	0.000317	0.0057	CbGeAlD
Bepridil—ATP1A1—adrenal gland—breast cancer	0.000315	0.00568	CbGeAlD
Bepridil—CALM1—uterus—breast cancer	0.000315	0.00568	CbGeAlD
Bepridil—KCNH2—endometrium—breast cancer	0.000311	0.00561	CbGeAlD
Bepridil—CALM2—pituitary gland—breast cancer	0.000311	0.0056	CbGeAlD
Bepridil—CALM2—adipose tissue—breast cancer	0.00031	0.00558	CbGeAlD
Bepridil—CALM1—pituitary gland—breast cancer	0.000309	0.00557	CbGeAlD
Bepridil—CALM1—adipose tissue—breast cancer	0.000308	0.00555	CbGeAlD
Bepridil—ATP1A1—bone marrow—breast cancer	0.000305	0.0055	CbGeAlD
Bepridil—ATP1A1—female gonad—breast cancer	0.000294	0.0053	CbGeAlD
Bepridil—KCNH2—uterus—breast cancer	0.000287	0.00517	CbGeAlD
Bepridil—CALM2—female reproductive system—breast cancer	0.000285	0.00513	CbGeAlD
Bepridil—CALM1—female reproductive system—breast cancer	0.000283	0.0051	CbGeAlD
Bepridil—KCNH2—pituitary gland—breast cancer	0.000282	0.00507	CbGeAlD
Bepridil—CALM2—adrenal gland—breast cancer	0.000278	0.005	CbGeAlD
Bepridil—CALM1—adrenal gland—breast cancer	0.000276	0.00498	CbGeAlD
Bepridil—CACNA1D—lymph node—breast cancer	0.000274	0.00494	CbGeAlD
Bepridil—ATP1A1—endocrine gland—breast cancer	0.000273	0.00493	CbGeAlD
Bepridil—CALM2—bone marrow—breast cancer	0.000269	0.00484	CbGeAlD
Bepridil—CALM1—bone marrow—breast cancer	0.000267	0.00482	CbGeAlD
Bepridil—CALM2—female gonad—breast cancer	0.000259	0.00466	CbGeAlD
Bepridil—KCNH2—female reproductive system—breast cancer	0.000258	0.00464	CbGeAlD
Bepridil—CALM1—female gonad—breast cancer	0.000258	0.00464	CbGeAlD
Bepridil—Trimethaphan—BCHE—breast cancer	0.000255	0.315	CrCbGaD
Bepridil—CACNA1C—lymph node—breast cancer	0.000253	0.00456	CbGeAlD
Bepridil—KCNH2—adrenal gland—breast cancer	0.000252	0.00453	CbGeAlD
Bepridil—KCNH2—bone marrow—breast cancer	0.000243	0.00438	CbGeAlD
Bepridil—CALM2—endocrine gland—breast cancer	0.000241	0.00434	CbGeAlD
Bepridil—CALM1—endocrine gland—breast cancer	0.00024	0.00432	CbGeAlD
Bepridil—KCNH2—female gonad—breast cancer	0.000235	0.00423	CbGeAlD
Bepridil—KCNH2—endocrine gland—breast cancer	0.000218	0.00393	CbGeAlD
Bepridil—CALM3—lymph node—breast cancer	0.000212	0.00382	CbGeAlD
Bepridil—ATP1A1—lymph node—breast cancer	0.000189	0.00341	CbGeAlD
Bepridil—ABCB1—embryo—breast cancer	0.000187	0.00336	CbGeAlD
Bepridil—CALM2—lymph node—breast cancer	0.000166	0.003	CbGeAlD
Bepridil—CALM1—lymph node—breast cancer	0.000166	0.00299	CbGeAlD
Bepridil—CYP2D6—female reproductive system—breast cancer	0.000157	0.00283	CbGeAlD
Bepridil—ABCB1—epithelium—breast cancer	0.000152	0.00274	CbGeAlD
Bepridil—KCNH2—lymph node—breast cancer	0.000151	0.00272	CbGeAlD
Bepridil—CYP2D6—female gonad—breast cancer	0.000143	0.00258	CbGeAlD
Bepridil—ABCB1—endometrium—breast cancer	0.000137	0.00246	CbGeAlD
Bepridil—CYP2D6—endocrine gland—breast cancer	0.000133	0.0024	CbGeAlD
Bepridil—ABCB1—uterus—breast cancer	0.000126	0.00227	CbGeAlD
Bepridil—ABCB1—pituitary gland—breast cancer	0.000124	0.00223	CbGeAlD
Bepridil—ABCB1—adipose tissue—breast cancer	0.000123	0.00222	CbGeAlD
Bepridil—Tripelennamine—CYP2D6—breast cancer	0.000118	0.145	CrCbGaD
Bepridil—ABCB1—female reproductive system—breast cancer	0.000113	0.00204	CbGeAlD
Bepridil—ABCB1—adrenal gland—breast cancer	0.00011	0.00199	CbGeAlD
Bepridil—ABCB1—bone marrow—breast cancer	0.000107	0.00192	CbGeAlD
Bepridil—ABCB1—female gonad—breast cancer	0.000103	0.00185	CbGeAlD
Bepridil—ABCB1—endocrine gland—breast cancer	9.57e-05	0.00172	CbGeAlD
Bepridil—Abdominal pain—Mitoxantrone—breast cancer	7.02e-05	0.000555	CcSEcCtD
Bepridil—Abdominal pain—Irinotecan—breast cancer	7.02e-05	0.000555	CcSEcCtD
Bepridil—Body temperature increased—Mitoxantrone—breast cancer	7.02e-05	0.000555	CcSEcCtD
Bepridil—Body temperature increased—Irinotecan—breast cancer	7.02e-05	0.000555	CcSEcCtD
Bepridil—Hyperhidrosis—Paclitaxel—breast cancer	7e-05	0.000554	CcSEcCtD
Bepridil—Drowsiness—Methotrexate—breast cancer	6.93e-05	0.000549	CcSEcCtD
Bepridil—Depression—Methotrexate—breast cancer	6.91e-05	0.000547	CcSEcCtD
Bepridil—Anorexia—Paclitaxel—breast cancer	6.9e-05	0.000546	CcSEcCtD
Bepridil—Gastritis—Doxorubicin—breast cancer	6.89e-05	0.000546	CcSEcCtD
Bepridil—Vision blurred—Capecitabine—breast cancer	6.86e-05	0.000543	CcSEcCtD
Bepridil—Body temperature increased—Gemcitabine—breast cancer	6.83e-05	0.000541	CcSEcCtD
Bepridil—Diphenhydramine—PTGS1—breast cancer	6.82e-05	0.0842	CrCbGaD
Bepridil—Tremor—Capecitabine—breast cancer	6.82e-05	0.00054	CcSEcCtD
Bepridil—Dizziness—Thiotepa—breast cancer	6.8e-05	0.000538	CcSEcCtD
Bepridil—Rash—Vinorelbine—breast cancer	6.78e-05	0.000537	CcSEcCtD
Bepridil—Dermatitis—Vinorelbine—breast cancer	6.78e-05	0.000537	CcSEcCtD
Bepridil—Headache—Vinorelbine—breast cancer	6.74e-05	0.000534	CcSEcCtD
Bepridil—Syncope—Docetaxel—breast cancer	6.74e-05	0.000534	CcSEcCtD
Bepridil—Influenza—Doxorubicin—breast cancer	6.73e-05	0.000533	CcSEcCtD
Bepridil—Body temperature increased—Fluorouracil—breast cancer	6.72e-05	0.000532	CcSEcCtD
Bepridil—Sweating—Methotrexate—breast cancer	6.65e-05	0.000526	CcSEcCtD
Bepridil—Palpitations—Docetaxel—breast cancer	6.64e-05	0.000526	CcSEcCtD
Bepridil—ABCB1—lymph node—breast cancer	6.62e-05	0.00119	CbGeAlD
Bepridil—Dextropropoxyphene—CYP2D6—breast cancer	6.61e-05	0.0815	CrCbGaD
Bepridil—Loss of consciousness—Docetaxel—breast cancer	6.61e-05	0.000523	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Paclitaxel—breast cancer	6.59e-05	0.000522	CcSEcCtD
Bepridil—Cough—Docetaxel—breast cancer	6.56e-05	0.000519	CcSEcCtD
Bepridil—Angina pectoris—Doxorubicin—breast cancer	6.56e-05	0.000519	CcSEcCtD
Bepridil—Insomnia—Paclitaxel—breast cancer	6.55e-05	0.000518	CcSEcCtD
Bepridil—Vertigo—Capecitabine—breast cancer	6.54e-05	0.000518	CcSEcCtD
Bepridil—Syncope—Capecitabine—breast cancer	6.53e-05	0.000517	CcSEcCtD
Bepridil—Paraesthesia—Paclitaxel—breast cancer	6.5e-05	0.000515	CcSEcCtD
Bepridil—Hypertension—Docetaxel—breast cancer	6.49e-05	0.000514	CcSEcCtD
Bepridil—Drowsiness—Epirubicin—breast cancer	6.49e-05	0.000514	CcSEcCtD
Bepridil—Rash—Thiotepa—breast cancer	6.48e-05	0.000513	CcSEcCtD
Bepridil—Dermatitis—Thiotepa—breast cancer	6.47e-05	0.000513	CcSEcCtD
Bepridil—Dyspnoea—Paclitaxel—breast cancer	6.45e-05	0.000511	CcSEcCtD
Bepridil—Headache—Thiotepa—breast cancer	6.44e-05	0.00051	CcSEcCtD
Bepridil—Somnolence—Paclitaxel—breast cancer	6.43e-05	0.000509	CcSEcCtD
Bepridil—Palpitations—Capecitabine—breast cancer	6.43e-05	0.000509	CcSEcCtD
Bepridil—Myalgia—Docetaxel—breast cancer	6.4e-05	0.000507	CcSEcCtD
Bepridil—Loss of consciousness—Capecitabine—breast cancer	6.4e-05	0.000506	CcSEcCtD
Bepridil—Nausea—Vinorelbine—breast cancer	6.39e-05	0.000506	CcSEcCtD
Bepridil—Dyspepsia—Paclitaxel—breast cancer	6.37e-05	0.000504	CcSEcCtD
Bepridil—Asthenia—Mitoxantrone—breast cancer	6.37e-05	0.000504	CcSEcCtD
Bepridil—Asthenia—Irinotecan—breast cancer	6.37e-05	0.000504	CcSEcCtD
Bepridil—Cough—Capecitabine—breast cancer	6.35e-05	0.000503	CcSEcCtD
Bepridil—Decreased appetite—Paclitaxel—breast cancer	6.29e-05	0.000498	CcSEcCtD
Bepridil—Hypertension—Capecitabine—breast cancer	6.28e-05	0.000497	CcSEcCtD
Bepridil—Dry mouth—Docetaxel—breast cancer	6.26e-05	0.000496	CcSEcCtD
Bepridil—Gastrointestinal disorder—Paclitaxel—breast cancer	6.25e-05	0.000495	CcSEcCtD
Bepridil—Sweating—Epirubicin—breast cancer	6.22e-05	0.000492	CcSEcCtD
Bepridil—Asthenia—Gemcitabine—breast cancer	6.2e-05	0.000491	CcSEcCtD
Bepridil—Myalgia—Capecitabine—breast cancer	6.2e-05	0.000491	CcSEcCtD
Bepridil—Pain—Paclitaxel—breast cancer	6.19e-05	0.00049	CcSEcCtD
Bepridil—Constipation—Paclitaxel—breast cancer	6.19e-05	0.00049	CcSEcCtD
Bepridil—Pharyngitis—Methotrexate—breast cancer	6.18e-05	0.000489	CcSEcCtD
Bepridil—Anxiety—Capecitabine—breast cancer	6.17e-05	0.000489	CcSEcCtD
Bepridil—Oedema—Docetaxel—breast cancer	6.13e-05	0.000486	CcSEcCtD
Bepridil—Nausea—Thiotepa—breast cancer	6.1e-05	0.000483	CcSEcCtD
Bepridil—Diarrhoea—Mitoxantrone—breast cancer	6.07e-05	0.000481	CcSEcCtD
Bepridil—Diarrhoea—Irinotecan—breast cancer	6.07e-05	0.000481	CcSEcCtD
Bepridil—Dry mouth—Capecitabine—breast cancer	6.06e-05	0.00048	CcSEcCtD
Bepridil—Shock—Docetaxel—breast cancer	6.04e-05	0.000478	CcSEcCtD
Bepridil—Drowsiness—Doxorubicin—breast cancer	6e-05	0.000475	CcSEcCtD
Bepridil—Oedema—Capecitabine—breast cancer	5.94e-05	0.00047	CcSEcCtD
Bepridil—Bradycardia—Epirubicin—breast cancer	5.93e-05	0.000469	CcSEcCtD
Bepridil—Gastrointestinal pain—Paclitaxel—breast cancer	5.92e-05	0.000469	CcSEcCtD
Bepridil—Diarrhoea—Gemcitabine—breast cancer	5.91e-05	0.000468	CcSEcCtD
Bepridil—Dizziness—Irinotecan—breast cancer	5.87e-05	0.000465	CcSEcCtD
Bepridil—Anorexia—Docetaxel—breast cancer	5.85e-05	0.000463	CcSEcCtD
Bepridil—Shock—Capecitabine—breast cancer	5.84e-05	0.000463	CcSEcCtD
Bepridil—Rhinitis—Epirubicin—breast cancer	5.84e-05	0.000462	CcSEcCtD
Bepridil—Diarrhoea—Fluorouracil—breast cancer	5.82e-05	0.00046	CcSEcCtD
Bepridil—Tinnitus—Methotrexate—breast cancer	5.8e-05	0.000459	CcSEcCtD
Bepridil—Pharyngitis—Epirubicin—breast cancer	5.78e-05	0.000458	CcSEcCtD
Bepridil—Cardiac disorder—Methotrexate—breast cancer	5.78e-05	0.000457	CcSEcCtD
Bepridil—Sweating—Doxorubicin—breast cancer	5.75e-05	0.000456	CcSEcCtD
Bepridil—Hyperhidrosis—Capecitabine—breast cancer	5.74e-05	0.000455	CcSEcCtD
Bepridil—Body temperature increased—Paclitaxel—breast cancer	5.72e-05	0.000453	CcSEcCtD
Bepridil—Abdominal pain—Paclitaxel—breast cancer	5.72e-05	0.000453	CcSEcCtD
Bepridil—Dextropropoxyphene—CYP3A4—breast cancer	5.67e-05	0.0699	CrCbGaD
Bepridil—Anorexia—Capecitabine—breast cancer	5.66e-05	0.000448	CcSEcCtD
Bepridil—Dizziness—Fluorouracil—breast cancer	5.62e-05	0.000445	CcSEcCtD
Bepridil—Fentanyl—CYP3A4—breast cancer	5.61e-05	0.0692	CrCbGaD
Bepridil—Rash—Irinotecan—breast cancer	5.6e-05	0.000443	CcSEcCtD
Bepridil—Rash—Mitoxantrone—breast cancer	5.6e-05	0.000443	CcSEcCtD
Bepridil—Dermatitis—Mitoxantrone—breast cancer	5.59e-05	0.000443	CcSEcCtD
Bepridil—Dermatitis—Irinotecan—breast cancer	5.59e-05	0.000443	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Docetaxel—breast cancer	5.59e-05	0.000443	CcSEcCtD
Bepridil—Headache—Mitoxantrone—breast cancer	5.56e-05	0.00044	CcSEcCtD
Bepridil—Headache—Irinotecan—breast cancer	5.56e-05	0.00044	CcSEcCtD
Bepridil—Insomnia—Docetaxel—breast cancer	5.55e-05	0.000439	CcSEcCtD
Bepridil—Paraesthesia—Docetaxel—breast cancer	5.51e-05	0.000436	CcSEcCtD
Bepridil—Bradycardia—Doxorubicin—breast cancer	5.49e-05	0.000434	CcSEcCtD
Bepridil—Dyspnoea—Docetaxel—breast cancer	5.47e-05	0.000433	CcSEcCtD
Bepridil—Somnolence—Docetaxel—breast cancer	5.45e-05	0.000432	CcSEcCtD
Bepridil—Rash—Gemcitabine—breast cancer	5.45e-05	0.000432	CcSEcCtD
Bepridil—Dermatitis—Gemcitabine—breast cancer	5.45e-05	0.000431	CcSEcCtD
Bepridil—Tinnitus—Epirubicin—breast cancer	5.43e-05	0.00043	CcSEcCtD
Bepridil—Headache—Gemcitabine—breast cancer	5.42e-05	0.000429	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Capecitabine—breast cancer	5.41e-05	0.000428	CcSEcCtD
Bepridil—Cardiac disorder—Epirubicin—breast cancer	5.41e-05	0.000428	CcSEcCtD
Bepridil—Rhinitis—Doxorubicin—breast cancer	5.4e-05	0.000428	CcSEcCtD
Bepridil—Dyspepsia—Docetaxel—breast cancer	5.4e-05	0.000428	CcSEcCtD
Bepridil—Insomnia—Capecitabine—breast cancer	5.37e-05	0.000425	CcSEcCtD
Bepridil—Rash—Fluorouracil—breast cancer	5.36e-05	0.000424	CcSEcCtD
Bepridil—Dermatitis—Fluorouracil—breast cancer	5.35e-05	0.000424	CcSEcCtD
Bepridil—Pharyngitis—Doxorubicin—breast cancer	5.35e-05	0.000423	CcSEcCtD
Bepridil—Paraesthesia—Capecitabine—breast cancer	5.33e-05	0.000422	CcSEcCtD
Bepridil—Decreased appetite—Docetaxel—breast cancer	5.33e-05	0.000422	CcSEcCtD
Bepridil—Headache—Fluorouracil—breast cancer	5.32e-05	0.000422	CcSEcCtD
Bepridil—Gastrointestinal disorder—Docetaxel—breast cancer	5.3e-05	0.000419	CcSEcCtD
Bepridil—Dyspnoea—Capecitabine—breast cancer	5.3e-05	0.000419	CcSEcCtD
Bepridil—Nausea—Mitoxantrone—breast cancer	5.27e-05	0.000417	CcSEcCtD
Bepridil—Nausea—Irinotecan—breast cancer	5.27e-05	0.000417	CcSEcCtD
Bepridil—Constipation—Docetaxel—breast cancer	5.25e-05	0.000415	CcSEcCtD
Bepridil—Pain—Docetaxel—breast cancer	5.25e-05	0.000415	CcSEcCtD
Bepridil—Dyspepsia—Capecitabine—breast cancer	5.23e-05	0.000414	CcSEcCtD
Bepridil—Arrhythmia—Epirubicin—breast cancer	5.2e-05	0.000412	CcSEcCtD
Bepridil—Asthenia—Paclitaxel—breast cancer	5.19e-05	0.000411	CcSEcCtD
Bepridil—Decreased appetite—Capecitabine—breast cancer	5.16e-05	0.000409	CcSEcCtD
Bepridil—Nausea—Gemcitabine—breast cancer	5.13e-05	0.000407	CcSEcCtD
Bepridil—Gastrointestinal disorder—Capecitabine—breast cancer	5.13e-05	0.000406	CcSEcCtD
Bepridil—Vision blurred—Methotrexate—breast cancer	5.11e-05	0.000404	CcSEcCtD
Bepridil—Pain—Capecitabine—breast cancer	5.08e-05	0.000402	CcSEcCtD
Bepridil—Constipation—Capecitabine—breast cancer	5.08e-05	0.000402	CcSEcCtD
Bepridil—Nausea—Fluorouracil—breast cancer	5.05e-05	0.0004	CcSEcCtD
Bepridil—Tinnitus—Doxorubicin—breast cancer	5.02e-05	0.000398	CcSEcCtD
Bepridil—Gastrointestinal pain—Docetaxel—breast cancer	5.02e-05	0.000397	CcSEcCtD
Bepridil—Cardiac disorder—Doxorubicin—breast cancer	5e-05	0.000396	CcSEcCtD
Bepridil—Flatulence—Epirubicin—breast cancer	5e-05	0.000396	CcSEcCtD
Bepridil—Tension—Epirubicin—breast cancer	4.98e-05	0.000394	CcSEcCtD
Bepridil—Benzphetamine—CYP3A4—breast cancer	4.97e-05	0.0613	CrCbGaD
Bepridil—Diarrhoea—Paclitaxel—breast cancer	4.95e-05	0.000392	CcSEcCtD
Bepridil—Nervousness—Epirubicin—breast cancer	4.92e-05	0.00039	CcSEcCtD
Bepridil—Vertigo—Methotrexate—breast cancer	4.87e-05	0.000385	CcSEcCtD
Bepridil—Gastrointestinal pain—Capecitabine—breast cancer	4.86e-05	0.000385	CcSEcCtD
Bepridil—Body temperature increased—Docetaxel—breast cancer	4.85e-05	0.000384	CcSEcCtD
Bepridil—Abdominal pain—Docetaxel—breast cancer	4.85e-05	0.000384	CcSEcCtD
Bepridil—Arrhythmia—Doxorubicin—breast cancer	4.81e-05	0.000381	CcSEcCtD
Bepridil—Dizziness—Paclitaxel—breast cancer	4.79e-05	0.000379	CcSEcCtD
Bepridil—Vision blurred—Epirubicin—breast cancer	4.78e-05	0.000378	CcSEcCtD
Bepridil—Phenoxybenzamine—CYP3A4—breast cancer	4.75e-05	0.0586	CrCbGaD
Bepridil—Cough—Methotrexate—breast cancer	4.73e-05	0.000374	CcSEcCtD
Bepridil—Abdominal pain—Capecitabine—breast cancer	4.7e-05	0.000372	CcSEcCtD
Bepridil—Body temperature increased—Capecitabine—breast cancer	4.7e-05	0.000372	CcSEcCtD
Bepridil—Fentanyl—ABCB1—breast cancer	4.67e-05	0.0576	CrCbGaD
Bepridil—Diphenhydramine—CYP2D6—breast cancer	4.64e-05	0.0573	CrCbGaD
Bepridil—Flatulence—Doxorubicin—breast cancer	4.62e-05	0.000366	CcSEcCtD
Bepridil—Myalgia—Methotrexate—breast cancer	4.61e-05	0.000365	CcSEcCtD
Bepridil—Tension—Doxorubicin—breast cancer	4.6e-05	0.000364	CcSEcCtD
Bepridil—Rash—Paclitaxel—breast cancer	4.56e-05	0.000361	CcSEcCtD
Bepridil—Dermatitis—Paclitaxel—breast cancer	4.56e-05	0.000361	CcSEcCtD
Bepridil—Nervousness—Doxorubicin—breast cancer	4.56e-05	0.000361	CcSEcCtD
Bepridil—Vertigo—Epirubicin—breast cancer	4.55e-05	0.000361	CcSEcCtD
Bepridil—Syncope—Epirubicin—breast cancer	4.55e-05	0.00036	CcSEcCtD
Bepridil—Headache—Paclitaxel—breast cancer	4.53e-05	0.000359	CcSEcCtD
Bepridil—Palpitations—Epirubicin—breast cancer	4.48e-05	0.000355	CcSEcCtD
Bepridil—Loss of consciousness—Epirubicin—breast cancer	4.46e-05	0.000353	CcSEcCtD
Bepridil—Cough—Epirubicin—breast cancer	4.42e-05	0.00035	CcSEcCtD
Bepridil—Vision blurred—Doxorubicin—breast cancer	4.42e-05	0.00035	CcSEcCtD
Bepridil—Asthenia—Docetaxel—breast cancer	4.4e-05	0.000348	CcSEcCtD
Bepridil—Hypertension—Epirubicin—breast cancer	4.38e-05	0.000347	CcSEcCtD
Bepridil—Myalgia—Epirubicin—breast cancer	4.32e-05	0.000342	CcSEcCtD
Bepridil—Anxiety—Epirubicin—breast cancer	4.3e-05	0.000341	CcSEcCtD
Bepridil—Nausea—Paclitaxel—breast cancer	4.3e-05	0.00034	CcSEcCtD
Bepridil—Hyperhidrosis—Methotrexate—breast cancer	4.27e-05	0.000338	CcSEcCtD
Bepridil—Asthenia—Capecitabine—breast cancer	4.26e-05	0.000337	CcSEcCtD
Bepridil—Dry mouth—Epirubicin—breast cancer	4.22e-05	0.000334	CcSEcCtD
Bepridil—Vertigo—Doxorubicin—breast cancer	4.21e-05	0.000334	CcSEcCtD
Bepridil—Anorexia—Methotrexate—breast cancer	4.21e-05	0.000334	CcSEcCtD
Bepridil—Syncope—Doxorubicin—breast cancer	4.21e-05	0.000333	CcSEcCtD
Bepridil—Diarrhoea—Docetaxel—breast cancer	4.2e-05	0.000332	CcSEcCtD
Bepridil—Palpitations—Doxorubicin—breast cancer	4.15e-05	0.000328	CcSEcCtD
Bepridil—Oedema—Epirubicin—breast cancer	4.14e-05	0.000328	CcSEcCtD
Bepridil—Loss of consciousness—Doxorubicin—breast cancer	4.12e-05	0.000326	CcSEcCtD
Bepridil—Cough—Doxorubicin—breast cancer	4.09e-05	0.000324	CcSEcCtD
Bepridil—Shock—Epirubicin—breast cancer	4.07e-05	0.000322	CcSEcCtD
Bepridil—Diarrhoea—Capecitabine—breast cancer	4.06e-05	0.000322	CcSEcCtD
Bepridil—Dizziness—Docetaxel—breast cancer	4.06e-05	0.000321	CcSEcCtD
Bepridil—Hypertension—Doxorubicin—breast cancer	4.05e-05	0.000321	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Methotrexate—breast cancer	4.03e-05	0.000319	CcSEcCtD
Bepridil—Hyperhidrosis—Epirubicin—breast cancer	4e-05	0.000317	CcSEcCtD
Bepridil—Insomnia—Methotrexate—breast cancer	4e-05	0.000317	CcSEcCtD
Bepridil—Myalgia—Doxorubicin—breast cancer	3.99e-05	0.000316	CcSEcCtD
Bepridil—Anxiety—Doxorubicin—breast cancer	3.98e-05	0.000315	CcSEcCtD
Bepridil—Paraesthesia—Methotrexate—breast cancer	3.97e-05	0.000314	CcSEcCtD
Bepridil—Anorexia—Epirubicin—breast cancer	3.94e-05	0.000312	CcSEcCtD
Bepridil—Dyspnoea—Methotrexate—breast cancer	3.94e-05	0.000312	CcSEcCtD
Bepridil—Somnolence—Methotrexate—breast cancer	3.93e-05	0.000311	CcSEcCtD
Bepridil—Dizziness—Capecitabine—breast cancer	3.93e-05	0.000311	CcSEcCtD
Bepridil—Dry mouth—Doxorubicin—breast cancer	3.91e-05	0.000309	CcSEcCtD
Bepridil—Dyspepsia—Methotrexate—breast cancer	3.89e-05	0.000308	CcSEcCtD
Bepridil—Rash—Docetaxel—breast cancer	3.87e-05	0.000306	CcSEcCtD
Bepridil—Dermatitis—Docetaxel—breast cancer	3.86e-05	0.000306	CcSEcCtD
Bepridil—Decreased appetite—Methotrexate—breast cancer	3.84e-05	0.000304	CcSEcCtD
Bepridil—Headache—Docetaxel—breast cancer	3.84e-05	0.000304	CcSEcCtD
Bepridil—Oedema—Doxorubicin—breast cancer	3.83e-05	0.000303	CcSEcCtD
Bepridil—Gastrointestinal disorder—Methotrexate—breast cancer	3.82e-05	0.000302	CcSEcCtD
Bepridil—Pain—Methotrexate—breast cancer	3.78e-05	0.000299	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Epirubicin—breast cancer	3.77e-05	0.000298	CcSEcCtD
Bepridil—Shock—Doxorubicin—breast cancer	3.77e-05	0.000298	CcSEcCtD
Bepridil—Rash—Capecitabine—breast cancer	3.74e-05	0.000297	CcSEcCtD
Bepridil—Insomnia—Epirubicin—breast cancer	3.74e-05	0.000296	CcSEcCtD
Bepridil—Dermatitis—Capecitabine—breast cancer	3.74e-05	0.000296	CcSEcCtD
Bepridil—Headache—Capecitabine—breast cancer	3.72e-05	0.000295	CcSEcCtD
Bepridil—Paraesthesia—Epirubicin—breast cancer	3.72e-05	0.000294	CcSEcCtD
Bepridil—Hyperhidrosis—Doxorubicin—breast cancer	3.7e-05	0.000293	CcSEcCtD
Bepridil—Dyspnoea—Epirubicin—breast cancer	3.69e-05	0.000292	CcSEcCtD
Bepridil—Somnolence—Epirubicin—breast cancer	3.68e-05	0.000291	CcSEcCtD
Bepridil—Anorexia—Doxorubicin—breast cancer	3.65e-05	0.000289	CcSEcCtD
Bepridil—Nausea—Docetaxel—breast cancer	3.64e-05	0.000289	CcSEcCtD
Bepridil—Dyspepsia—Epirubicin—breast cancer	3.64e-05	0.000288	CcSEcCtD
Bepridil—Gastrointestinal pain—Methotrexate—breast cancer	3.62e-05	0.000286	CcSEcCtD
Bepridil—Decreased appetite—Epirubicin—breast cancer	3.6e-05	0.000285	CcSEcCtD
Bepridil—Gastrointestinal disorder—Epirubicin—breast cancer	3.57e-05	0.000283	CcSEcCtD
Bepridil—Pain—Epirubicin—breast cancer	3.54e-05	0.00028	CcSEcCtD
Bepridil—Constipation—Epirubicin—breast cancer	3.54e-05	0.00028	CcSEcCtD
Bepridil—Nausea—Capecitabine—breast cancer	3.53e-05	0.000279	CcSEcCtD
Bepridil—Abdominal pain—Methotrexate—breast cancer	3.5e-05	0.000277	CcSEcCtD
Bepridil—Body temperature increased—Methotrexate—breast cancer	3.5e-05	0.000277	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Doxorubicin—breast cancer	3.49e-05	0.000276	CcSEcCtD
Bepridil—Insomnia—Doxorubicin—breast cancer	3.46e-05	0.000274	CcSEcCtD
Bepridil—Paraesthesia—Doxorubicin—breast cancer	3.44e-05	0.000272	CcSEcCtD
Bepridil—Dyspnoea—Doxorubicin—breast cancer	3.41e-05	0.00027	CcSEcCtD
Bepridil—Somnolence—Doxorubicin—breast cancer	3.4e-05	0.000269	CcSEcCtD
Bepridil—Gastrointestinal pain—Epirubicin—breast cancer	3.38e-05	0.000268	CcSEcCtD
Bepridil—Dyspepsia—Doxorubicin—breast cancer	3.37e-05	0.000267	CcSEcCtD
Bepridil—Decreased appetite—Doxorubicin—breast cancer	3.33e-05	0.000264	CcSEcCtD
Bepridil—Gastrointestinal disorder—Doxorubicin—breast cancer	3.31e-05	0.000262	CcSEcCtD
Bepridil—Constipation—Doxorubicin—breast cancer	3.27e-05	0.000259	CcSEcCtD
Bepridil—Pain—Doxorubicin—breast cancer	3.27e-05	0.000259	CcSEcCtD
Bepridil—Body temperature increased—Epirubicin—breast cancer	3.27e-05	0.000259	CcSEcCtD
Bepridil—Abdominal pain—Epirubicin—breast cancer	3.27e-05	0.000259	CcSEcCtD
Bepridil—Asthenia—Methotrexate—breast cancer	3.17e-05	0.000251	CcSEcCtD
Bepridil—Gastrointestinal pain—Doxorubicin—breast cancer	3.13e-05	0.000248	CcSEcCtD
Bepridil—Body temperature increased—Doxorubicin—breast cancer	3.03e-05	0.00024	CcSEcCtD
Bepridil—Abdominal pain—Doxorubicin—breast cancer	3.03e-05	0.00024	CcSEcCtD
Bepridil—Diarrhoea—Methotrexate—breast cancer	3.03e-05	0.00024	CcSEcCtD
Bepridil—Asthenia—Epirubicin—breast cancer	2.97e-05	0.000235	CcSEcCtD
Bepridil—Dizziness—Methotrexate—breast cancer	2.92e-05	0.000232	CcSEcCtD
Bepridil—Diarrhoea—Epirubicin—breast cancer	2.83e-05	0.000224	CcSEcCtD
Bepridil—Rash—Methotrexate—breast cancer	2.79e-05	0.000221	CcSEcCtD
Bepridil—Dermatitis—Methotrexate—breast cancer	2.79e-05	0.000221	CcSEcCtD
Bepridil—Headache—Methotrexate—breast cancer	2.77e-05	0.000219	CcSEcCtD
Bepridil—Asthenia—Doxorubicin—breast cancer	2.75e-05	0.000217	CcSEcCtD
Bepridil—Dizziness—Epirubicin—breast cancer	2.74e-05	0.000217	CcSEcCtD
Bepridil—Nausea—Methotrexate—breast cancer	2.63e-05	0.000208	CcSEcCtD
Bepridil—Diarrhoea—Doxorubicin—breast cancer	2.62e-05	0.000207	CcSEcCtD
Bepridil—Rash—Epirubicin—breast cancer	2.61e-05	0.000207	CcSEcCtD
Bepridil—Dermatitis—Epirubicin—breast cancer	2.61e-05	0.000206	CcSEcCtD
Bepridil—Headache—Epirubicin—breast cancer	2.59e-05	0.000205	CcSEcCtD
Bepridil—Dizziness—Doxorubicin—breast cancer	2.53e-05	0.0002	CcSEcCtD
Bepridil—Nausea—Epirubicin—breast cancer	2.46e-05	0.000195	CcSEcCtD
Bepridil—Rash—Doxorubicin—breast cancer	2.41e-05	0.000191	CcSEcCtD
Bepridil—Dermatitis—Doxorubicin—breast cancer	2.41e-05	0.000191	CcSEcCtD
Bepridil—Headache—Doxorubicin—breast cancer	2.4e-05	0.00019	CcSEcCtD
Bepridil—Nausea—Doxorubicin—breast cancer	2.27e-05	0.00018	CcSEcCtD
Bepridil—CALM2—Innate Immune System—AKT1—breast cancer	1.12e-06	8.65e-06	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—AKT1—breast cancer	1.12e-06	8.65e-06	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—AKT1—breast cancer	1.11e-06	8.58e-06	CbGpPWpGaD
Bepridil—CALM3—Disease—CTNNB1—breast cancer	1.11e-06	8.56e-06	CbGpPWpGaD
Bepridil—CALM2—Immune System—MAPK8—breast cancer	1.1e-06	8.55e-06	CbGpPWpGaD
Bepridil—CALM1—Immune System—MAPK8—breast cancer	1.1e-06	8.55e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—PIK3CG—breast cancer	1.1e-06	8.53e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—APC—breast cancer	1.1e-06	8.53e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—PIK3CG—breast cancer	1.1e-06	8.53e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—APC—breast cancer	1.1e-06	8.53e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—KIT—breast cancer	1.1e-06	8.53e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—KIT—breast cancer	1.1e-06	8.53e-06	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—AKT1—breast cancer	1.1e-06	8.49e-06	CbGpPWpGaD
Bepridil—CALM2—Metabolism—NOS3—breast cancer	1.09e-06	8.47e-06	CbGpPWpGaD
Bepridil—CALM1—Metabolism—NOS3—breast cancer	1.09e-06	8.47e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—MAPK3—breast cancer	1.09e-06	8.45e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—EGF—breast cancer	1.09e-06	8.43e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—EGF—breast cancer	1.09e-06	8.43e-06	CbGpPWpGaD
Bepridil—CALM3—Immune System—SRC—breast cancer	1.08e-06	8.38e-06	CbGpPWpGaD
Bepridil—CALM3—Disease—CDKN1A—breast cancer	1.08e-06	8.36e-06	CbGpPWpGaD
Bepridil—CALM3—Disease—PTEN—breast cancer	1.08e-06	8.34e-06	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—AKT1—breast cancer	1.07e-06	8.3e-06	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—AKT1—breast cancer	1.07e-06	8.3e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—BRAF—breast cancer	1.07e-06	8.29e-06	CbGpPWpGaD
Bepridil—CALM1—Disease—CTNNB1—breast cancer	1.07e-06	8.28e-06	CbGpPWpGaD
Bepridil—CALM2—Disease—CTNNB1—breast cancer	1.07e-06	8.28e-06	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—CAV1—breast cancer	1.07e-06	8.27e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—MAPK3—breast cancer	1.06e-06	8.17e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—MAPK3—breast cancer	1.06e-06	8.17e-06	CbGpPWpGaD
Bepridil—CALM2—Immune System—SRC—breast cancer	1.05e-06	8.1e-06	CbGpPWpGaD
Bepridil—CALM1—Immune System—SRC—breast cancer	1.05e-06	8.1e-06	CbGpPWpGaD
Bepridil—CALM1—Disease—CDKN1A—breast cancer	1.05e-06	8.09e-06	CbGpPWpGaD
Bepridil—CALM2—Disease—CDKN1A—breast cancer	1.05e-06	8.09e-06	CbGpPWpGaD
Bepridil—CALM3—Metabolism—PIK3CB—breast cancer	1.04e-06	8.08e-06	CbGpPWpGaD
Bepridil—CALM3—Immune System—STAT3—breast cancer	1.04e-06	8.08e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—IGF1—breast cancer	1.04e-06	8.08e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—AKT2—breast cancer	1.04e-06	8.07e-06	CbGpPWpGaD
Bepridil—CALM2—Disease—PTEN—breast cancer	1.04e-06	8.07e-06	CbGpPWpGaD
Bepridil—CALM1—Disease—PTEN—breast cancer	1.04e-06	8.07e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—EGFR—breast cancer	1.04e-06	8.04e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—BRAF—breast cancer	1.04e-06	8.02e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—BRAF—breast cancer	1.04e-06	8.02e-06	CbGpPWpGaD
Bepridil—CALM3—Metabolism—PTGS2—breast cancer	1.04e-06	8.01e-06	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—PIK3CG—breast cancer	1.03e-06	7.99e-06	CbGpPWpGaD
Bepridil—CALM2—Metabolism—PIK3CB—breast cancer	1.01e-06	7.82e-06	CbGpPWpGaD
Bepridil—CALM1—Metabolism—PIK3CB—breast cancer	1.01e-06	7.82e-06	CbGpPWpGaD
Bepridil—CALM1—Immune System—STAT3—breast cancer	1.01e-06	7.81e-06	CbGpPWpGaD
Bepridil—CALM2—Immune System—STAT3—breast cancer	1.01e-06	7.81e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—IGF1—breast cancer	1.01e-06	7.81e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—IGF1—breast cancer	1.01e-06	7.81e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—AKT2—breast cancer	1.01e-06	7.81e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—AKT2—breast cancer	1.01e-06	7.81e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—EGFR—breast cancer	1e-06	7.77e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—EGFR—breast cancer	1e-06	7.77e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—PIK3CD—breast cancer	1e-06	7.75e-06	CbGpPWpGaD
Bepridil—CALM2—Metabolism—PTGS2—breast cancer	1e-06	7.75e-06	CbGpPWpGaD
Bepridil—CALM1—Metabolism—PTGS2—breast cancer	1e-06	7.75e-06	CbGpPWpGaD
Bepridil—CALM3—Disease—SRC—breast cancer	1e-06	7.73e-06	CbGpPWpGaD
Bepridil—CALM3—Immune System—MAPK3—breast cancer	9.98e-07	7.72e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—SERPINE1—breast cancer	9.91e-07	7.67e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—KRAS—breast cancer	9.81e-07	7.59e-06	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—PIK3CG—breast cancer	9.74e-07	7.53e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—PIK3CD—breast cancer	9.7e-07	7.5e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—PIK3CD—breast cancer	9.7e-07	7.5e-06	CbGpPWpGaD
Bepridil—CALM1—Disease—SRC—breast cancer	9.67e-07	7.48e-06	CbGpPWpGaD
Bepridil—CALM2—Disease—SRC—breast cancer	9.67e-07	7.48e-06	CbGpPWpGaD
Bepridil—CALM2—Immune System—MAPK3—breast cancer	9.65e-07	7.47e-06	CbGpPWpGaD
Bepridil—CALM1—Immune System—MAPK3—breast cancer	9.65e-07	7.47e-06	CbGpPWpGaD
Bepridil—CALM3—Disease—STAT3—breast cancer	9.64e-07	7.46e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—SERPINE1—breast cancer	9.59e-07	7.42e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—SERPINE1—breast cancer	9.59e-07	7.42e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—KRAS—breast cancer	9.49e-07	7.34e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—KRAS—breast cancer	9.49e-07	7.34e-06	CbGpPWpGaD
Bepridil—CALM3—Immune System—EGFR—breast cancer	9.49e-07	7.34e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—NOS3—breast cancer	9.46e-07	7.32e-06	CbGpPWpGaD
Bepridil—CALM1—Disease—STAT3—breast cancer	9.33e-07	7.21e-06	CbGpPWpGaD
Bepridil—CALM2—Disease—STAT3—breast cancer	9.33e-07	7.21e-06	CbGpPWpGaD
Bepridil—CALM3—Disease—MAPK3—breast cancer	9.21e-07	7.13e-06	CbGpPWpGaD
Bepridil—CALM1—Immune System—EGFR—breast cancer	9.18e-07	7.1e-06	CbGpPWpGaD
Bepridil—CALM2—Immune System—EGFR—breast cancer	9.18e-07	7.1e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—NOS3—breast cancer	9.16e-07	7.08e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—NOS3—breast cancer	9.16e-07	7.08e-06	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—PIK3CD—breast cancer	9.08e-07	7.03e-06	CbGpPWpGaD
Bepridil—CALM3—Metabolism—PTEN—breast cancer	9.03e-07	6.98e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—PIK3CA—breast cancer	9.02e-07	6.97e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—MDM2—breast cancer	8.98e-07	6.95e-06	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—ALB—breast cancer	8.97e-07	6.94e-06	CbGpPWpGaD
Bepridil—CALM3—Immune System—KRAS—breast cancer	8.97e-07	6.94e-06	CbGpPWpGaD
Bepridil—CALM3—Disease—MYC—breast cancer	8.96e-07	6.93e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—RAF1—breast cancer	8.95e-07	6.92e-06	CbGpPWpGaD
Bepridil—CALM3—Disease—TGFB1—breast cancer	8.94e-07	6.91e-06	CbGpPWpGaD
Bepridil—CALM2—Disease—MAPK3—breast cancer	8.91e-07	6.89e-06	CbGpPWpGaD
Bepridil—CALM1—Disease—MAPK3—breast cancer	8.91e-07	6.89e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—RELA—breast cancer	8.91e-07	6.89e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—ERBB2—breast cancer	8.85e-07	6.85e-06	CbGpPWpGaD
Bepridil—CALM3—Disease—EGFR—breast cancer	8.76e-07	6.78e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—MTOR—breast cancer	8.74e-07	6.76e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—PIK3CB—breast cancer	8.74e-07	6.76e-06	CbGpPWpGaD
Bepridil—CALM1—Metabolism—PTEN—breast cancer	8.73e-07	6.76e-06	CbGpPWpGaD
Bepridil—CALM2—Metabolism—PTEN—breast cancer	8.73e-07	6.76e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—PIK3CA—breast cancer	8.72e-07	6.75e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—PIK3CA—breast cancer	8.72e-07	6.75e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—MDM2—breast cancer	8.69e-07	6.72e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—MDM2—breast cancer	8.69e-07	6.72e-06	CbGpPWpGaD
Bepridil—CALM2—Immune System—KRAS—breast cancer	8.67e-07	6.71e-06	CbGpPWpGaD
Bepridil—CALM1—Immune System—KRAS—breast cancer	8.67e-07	6.71e-06	CbGpPWpGaD
Bepridil—CALM1—Disease—MYC—breast cancer	8.67e-07	6.7e-06	CbGpPWpGaD
Bepridil—CALM2—Disease—MYC—breast cancer	8.67e-07	6.7e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—RAF1—breast cancer	8.66e-07	6.7e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—RAF1—breast cancer	8.66e-07	6.7e-06	CbGpPWpGaD
Bepridil—CALM2—Disease—TGFB1—breast cancer	8.65e-07	6.69e-06	CbGpPWpGaD
Bepridil—CALM1—Disease—TGFB1—breast cancer	8.65e-07	6.69e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—RELA—breast cancer	8.62e-07	6.67e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—RELA—breast cancer	8.62e-07	6.67e-06	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—NOS3—breast cancer	8.58e-07	6.64e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—ERBB2—breast cancer	8.56e-07	6.62e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—ERBB2—breast cancer	8.56e-07	6.62e-06	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—PIK3CD—breast cancer	8.56e-07	6.62e-06	CbGpPWpGaD
Bepridil—CALM1—Disease—EGFR—breast cancer	8.48e-07	6.56e-06	CbGpPWpGaD
Bepridil—CALM2—Disease—EGFR—breast cancer	8.48e-07	6.56e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—MTOR—breast cancer	8.45e-07	6.54e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—PIK3CB—breast cancer	8.45e-07	6.54e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—PIK3CB—breast cancer	8.45e-07	6.54e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—MTOR—breast cancer	8.45e-07	6.54e-06	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—ALB—breast cancer	8.45e-07	6.54e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CXCL8—breast cancer	8.4e-07	6.49e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—HRAS—breast cancer	8.34e-07	6.45e-06	CbGpPWpGaD
Bepridil—CALM3—Disease—KRAS—breast cancer	8.28e-07	6.4e-06	CbGpPWpGaD
Bepridil—CALM3—Immune System—PIK3CA—breast cancer	8.24e-07	6.37e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CDKN1B—breast cancer	8.2e-07	6.34e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CXCL8—breast cancer	8.12e-07	6.28e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CXCL8—breast cancer	8.12e-07	6.28e-06	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—NOS3—breast cancer	8.08e-07	6.25e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—HRAS—breast cancer	8.07e-07	6.24e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—HRAS—breast cancer	8.07e-07	6.24e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CASP3—breast cancer	8.04e-07	6.22e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—IL2—breast cancer	8.02e-07	6.21e-06	CbGpPWpGaD
Bepridil—CALM2—Disease—KRAS—breast cancer	8.01e-07	6.19e-06	CbGpPWpGaD
Bepridil—CALM1—Disease—KRAS—breast cancer	8.01e-07	6.19e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—IL6—breast cancer	7.98e-07	6.18e-06	CbGpPWpGaD
Bepridil—CALM2—Immune System—PIK3CA—breast cancer	7.97e-07	6.16e-06	CbGpPWpGaD
Bepridil—CALM1—Immune System—PIK3CA—breast cancer	7.97e-07	6.16e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CDKN1B—breast cancer	7.93e-07	6.14e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CDKN1B—breast cancer	7.93e-07	6.14e-06	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—PIK3CB—breast cancer	7.92e-07	6.13e-06	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—PTGS2—breast cancer	7.85e-07	6.07e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CCND1—breast cancer	7.82e-07	6.05e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—JUN—breast cancer	7.81e-07	6.04e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CASP3—breast cancer	7.77e-07	6.01e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CASP3—breast cancer	7.77e-07	6.01e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—IL2—breast cancer	7.76e-07	6e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—IL2—breast cancer	7.76e-07	6e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CTNNB1—breast cancer	7.75e-07	5.99e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—IL6—breast cancer	7.72e-07	5.97e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—IL6—breast cancer	7.72e-07	5.97e-06	CbGpPWpGaD
Bepridil—CALM3—Immune System—HRAS—breast cancer	7.62e-07	5.9e-06	CbGpPWpGaD
Bepridil—CALM3—Disease—PIK3CA—breast cancer	7.61e-07	5.88e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—MMP9—breast cancer	7.59e-07	5.87e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CDKN1A—breast cancer	7.57e-07	5.85e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CCND1—breast cancer	7.57e-07	5.85e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CCND1—breast cancer	7.57e-07	5.85e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—JUN—breast cancer	7.55e-07	5.84e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—JUN—breast cancer	7.55e-07	5.84e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—PTEN—breast cancer	7.55e-07	5.84e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CTNNB1—breast cancer	7.49e-07	5.8e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CTNNB1—breast cancer	7.49e-07	5.8e-06	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—PIK3CB—breast cancer	7.46e-07	5.77e-06	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—PTGS2—breast cancer	7.39e-07	5.72e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—MAPK8—breast cancer	7.39e-07	5.71e-06	CbGpPWpGaD
Bepridil—CALM2—Immune System—HRAS—breast cancer	7.37e-07	5.7e-06	CbGpPWpGaD
Bepridil—CALM1—Immune System—HRAS—breast cancer	7.37e-07	5.7e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—AKT1—breast cancer	7.37e-07	5.7e-06	CbGpPWpGaD
Bepridil—CALM1—Disease—PIK3CA—breast cancer	7.36e-07	5.69e-06	CbGpPWpGaD
Bepridil—CALM2—Disease—PIK3CA—breast cancer	7.36e-07	5.69e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—MMP9—breast cancer	7.35e-07	5.68e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—MMP9—breast cancer	7.35e-07	5.68e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CDKN1A—breast cancer	7.32e-07	5.66e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CDKN1A—breast cancer	7.32e-07	5.66e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—PTEN—breast cancer	7.3e-07	5.65e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—PTEN—breast cancer	7.3e-07	5.65e-06	CbGpPWpGaD
Bepridil—CALM3—Immune System—IL6—breast cancer	7.29e-07	5.64e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—MAPK8—breast cancer	7.14e-07	5.53e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—MAPK8—breast cancer	7.14e-07	5.53e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—AKT1—breast cancer	7.12e-07	5.51e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—AKT1—breast cancer	7.12e-07	5.51e-06	CbGpPWpGaD
Bepridil—CALM1—Immune System—IL6—breast cancer	7.06e-07	5.46e-06	CbGpPWpGaD
Bepridil—CALM2—Immune System—IL6—breast cancer	7.06e-07	5.46e-06	CbGpPWpGaD
Bepridil—CALM3—Disease—HRAS—breast cancer	7.04e-07	5.44e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—SRC—breast cancer	7e-07	5.42e-06	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—PTEN—breast cancer	6.84e-07	5.29e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—VEGFA—breast cancer	6.82e-07	5.27e-06	CbGpPWpGaD
Bepridil—CALM2—Disease—HRAS—breast cancer	6.81e-07	5.27e-06	CbGpPWpGaD
Bepridil—CALM1—Disease—HRAS—breast cancer	6.81e-07	5.27e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—SRC—breast cancer	6.77e-07	5.24e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—SRC—breast cancer	6.77e-07	5.24e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—STAT3—breast cancer	6.75e-07	5.22e-06	CbGpPWpGaD
Bepridil—CALM3—Disease—IL6—breast cancer	6.73e-07	5.21e-06	CbGpPWpGaD
Bepridil—CALM3—Immune System—AKT1—breast cancer	6.73e-07	5.21e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—VEGFA—breast cancer	6.6e-07	5.1e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—VEGFA—breast cancer	6.6e-07	5.1e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—STAT3—breast cancer	6.53e-07	5.05e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—STAT3—breast cancer	6.53e-07	5.05e-06	CbGpPWpGaD
Bepridil—CALM2—Disease—IL6—breast cancer	6.51e-07	5.04e-06	CbGpPWpGaD
Bepridil—CALM1—Disease—IL6—breast cancer	6.51e-07	5.04e-06	CbGpPWpGaD
Bepridil—CALM2—Immune System—AKT1—breast cancer	6.51e-07	5.04e-06	CbGpPWpGaD
Bepridil—CALM1—Immune System—AKT1—breast cancer	6.51e-07	5.04e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—MAPK3—breast cancer	6.45e-07	4.99e-06	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—PTEN—breast cancer	6.45e-07	4.99e-06	CbGpPWpGaD
Bepridil—CALM3—Metabolism—PIK3CA—breast cancer	6.37e-07	4.93e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—MYC—breast cancer	6.27e-07	4.85e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—TGFB1—breast cancer	6.26e-07	4.84e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—MAPK3—breast cancer	6.24e-07	4.83e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—MAPK3—breast cancer	6.24e-07	4.83e-06	CbGpPWpGaD
Bepridil—CALM3—Disease—AKT1—breast cancer	6.21e-07	4.81e-06	CbGpPWpGaD
Bepridil—CALM2—Metabolism—PIK3CA—breast cancer	6.16e-07	4.77e-06	CbGpPWpGaD
Bepridil—CALM1—Metabolism—PIK3CA—breast cancer	6.16e-07	4.77e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—EGFR—breast cancer	6.14e-07	4.75e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—MYC—breast cancer	6.07e-07	4.69e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—MYC—breast cancer	6.07e-07	4.69e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—TGFB1—breast cancer	6.05e-07	4.68e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—TGFB1—breast cancer	6.05e-07	4.68e-06	CbGpPWpGaD
Bepridil—CALM2—Disease—AKT1—breast cancer	6.01e-07	4.65e-06	CbGpPWpGaD
Bepridil—CALM1—Disease—AKT1—breast cancer	6.01e-07	4.65e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—EGFR—breast cancer	5.94e-07	4.59e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—EGFR—breast cancer	5.94e-07	4.59e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—KRAS—breast cancer	5.8e-07	4.48e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—KRAS—breast cancer	5.61e-07	4.34e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—KRAS—breast cancer	5.61e-07	4.34e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—PIK3CA—breast cancer	5.33e-07	4.12e-06	CbGpPWpGaD
Bepridil—CALM3—Metabolism—AKT1—breast cancer	5.2e-07	4.02e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—TP53—breast cancer	5.15e-07	3.99e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—PIK3CA—breast cancer	5.15e-07	3.99e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—PIK3CA—breast cancer	5.15e-07	3.99e-06	CbGpPWpGaD
Bepridil—CALM2—Metabolism—AKT1—breast cancer	5.03e-07	3.89e-06	CbGpPWpGaD
Bepridil—CALM1—Metabolism—AKT1—breast cancer	5.03e-07	3.89e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—TP53—breast cancer	4.98e-07	3.86e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—TP53—breast cancer	4.98e-07	3.86e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—HRAS—breast cancer	4.93e-07	3.81e-06	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—PIK3CA—breast cancer	4.83e-07	3.73e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—HRAS—breast cancer	4.77e-07	3.69e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—HRAS—breast cancer	4.77e-07	3.69e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—IL6—breast cancer	4.72e-07	3.65e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—IL6—breast cancer	4.56e-07	3.53e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—IL6—breast cancer	4.56e-07	3.53e-06	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—PIK3CA—breast cancer	4.55e-07	3.52e-06	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—AKT1—breast cancer	4.35e-07	3.37e-06	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—AKT1—breast cancer	4.21e-07	3.26e-06	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—AKT1—breast cancer	4.21e-07	3.26e-06	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—AKT1—breast cancer	3.94e-07	3.05e-06	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—AKT1—breast cancer	3.72e-07	2.87e-06	CbGpPWpGaD
